Equigene has assembled a team uniquely qualified to
deliver these benefits. The team includes world-class
experts in genetics/genomics, equine physiology, and
thoroughbred training and breeding.
Carlo Quinonez, Ph.D.
Adam Sadowsky
Barbara Wold, Ph.D.
Girish Aakalu, Ph.D.
Daniel Meulemans, Ph.D.
President
Dr. Carlo Quinonez was a cofounder and managing partner at Visopia, a company that captured over 80% of the concept car lighting market. As an Entrepreneurial Fellow at the California Institute of Technology. Dr. Quinonez completed course work in patent law, management of technology and innovation, accounting, finance, and marketing. Dr. Quinonez received a PhD in Biology from the California Institute of Technology and a BS in Biology from San Diego State University.
Dr. Carlo Quinonez was a cofounder and managing partner at Visopia, a company that captured over 80% of the concept car lighting market. As an Entrepreneurial Fellow at the California Institute of Technology. Dr. Quinonez completed course work in patent law, management of technology and innovation, accounting, finance, and marketing. Dr. Quinonez received a PhD in Biology from the California Institute of Technology and a BS in Biology from San Diego State University.
Chief Operating
Officer
Adam Sadowsky recently left his position as COO & CTO of a video game publisher, OGPlanet to start Equigene. Previously, he co-founded Travelkey, a software development company, co-founded and served as President of Knock Knock, an award-winning design & manufacturing company. He also served as IT Director, Support Services for CB Richard Ellis, the world’s largest commercial real estate company, where he grew and managed a team of 125 to deliver technology support services to all 18,000 employees. In addition to career pursuits, Adam co-founded the non-profit IBD Support Foundation in January of 2007 to provide support services for patients with Inflammatory Bowel Disease and their families. Mr. Sadowsky graduated from the University of Southern California with a BS in Computer Science.
Adam Sadowsky recently left his position as COO & CTO of a video game publisher, OGPlanet to start Equigene. Previously, he co-founded Travelkey, a software development company, co-founded and served as President of Knock Knock, an award-winning design & manufacturing company. He also served as IT Director, Support Services for CB Richard Ellis, the world’s largest commercial real estate company, where he grew and managed a team of 125 to deliver technology support services to all 18,000 employees. In addition to career pursuits, Adam co-founded the non-profit IBD Support Foundation in January of 2007 to provide support services for patients with Inflammatory Bowel Disease and their families. Mr. Sadowsky graduated from the University of Southern California with a BS in Computer Science.
Advisory Board
Dr. Barbara Wold is the Director of the Beckman Institute at the California Institute of Technology. She is an authority on the genetic basis of mammalian development. Dr. Wold has been active in national and international science policy concerned with the Human Genome Project, advising the National Institutes of Health and the Department of Energy programs in genomics. Dr. Wold has been a professor of biology at Caltech since 1981. She earned her bachelor's degree in 1973 from Arizona State, her Ph.D. from Caltech in molecular developmental biology, and did postdoctoral research at Columbia College of Physicians and Surgeons.
Dr. Barbara Wold is the Director of the Beckman Institute at the California Institute of Technology. She is an authority on the genetic basis of mammalian development. Dr. Wold has been active in national and international science policy concerned with the Human Genome Project, advising the National Institutes of Health and the Department of Energy programs in genomics. Dr. Wold has been a professor of biology at Caltech since 1981. She earned her bachelor's degree in 1973 from Arizona State, her Ph.D. from Caltech in molecular developmental biology, and did postdoctoral research at Columbia College of Physicians and Surgeons.
Advisory Board
Girish Aakalu currently serves as Director of Strategic Management for Pfizer's Global Research and Development organization. Prior to joining Pfizer, Girish held positions in Genentech's Business Development and Market Planning groups where he was responsible for leading a wide range of transactions and serving as the commercial strategy lead for several of Genentech's pipeline products. Girish began his career at L.E.K. Consulting where he helped life science tools, diagnostics, and biopharmaceutical clients with key strategic and transactional issues. Girish received a Ph.D. in Biology from the California Institute of Technology and a B.A. in Biophysics from the Johns Hopkins University. His scientific work has been published in a number of top-tier journals, including Science.
Girish Aakalu currently serves as Director of Strategic Management for Pfizer's Global Research and Development organization. Prior to joining Pfizer, Girish held positions in Genentech's Business Development and Market Planning groups where he was responsible for leading a wide range of transactions and serving as the commercial strategy lead for several of Genentech's pipeline products. Girish began his career at L.E.K. Consulting where he helped life science tools, diagnostics, and biopharmaceutical clients with key strategic and transactional issues. Girish received a Ph.D. in Biology from the California Institute of Technology and a B.A. in Biophysics from the Johns Hopkins University. His scientific work has been published in a number of top-tier journals, including Science.
Advisory Board
Dr. Daniel Meulemans is Senior Research Fellow in Biology at the California Institute of Technology. Dr. Meulemans studies how regulatory DNA is modified over time to cause new biological features. Dr. Meulemans received a PhD in Biology from the California Institute of Technology and a BS with Highest Honors in Zoology from the University of Hawaii.
Dr. Daniel Meulemans is Senior Research Fellow in Biology at the California Institute of Technology. Dr. Meulemans studies how regulatory DNA is modified over time to cause new biological features. Dr. Meulemans received a PhD in Biology from the California Institute of Technology and a BS with Highest Honors in Zoology from the University of Hawaii.